Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606673077> ?p ?o ?g. }
- W2606673077 endingPage "1710" @default.
- W2606673077 startingPage "1691" @default.
- W2606673077 abstract "Mitogen-activated protein kinase (MAPK) pathway antagonists induce profound clinical responses in advanced cutaneous melanoma, but complete remissions are frustrated by the development of acquired resistance. Before resistance emerges, adaptive responses establish a mutation-independent drug tolerance. Antagonizing these adaptive responses could improve drug effects, thereby thwarting the emergence of acquired resistance. In this study, we reveal that inflammatory niches consisting of tumor-associated macrophages and fibroblasts contribute to treatment tolerance through a cytokine-signaling network that involves macrophage-derived IL-1β and fibroblast-derived CXCR2 ligands. Fibroblasts require IL-1β to produce CXCR2 ligands, and loss of host IL-1R signaling in vivo reduces melanoma growth. In tumors from patients on treatment, signaling from inflammatory niches is amplified in the presence of MAPK inhibitors. Signaling from inflammatory niches counteracts combined BRAF/MEK (MAPK/extracellular signal–regulated kinase kinase) inhibitor treatment, and consequently, inhibiting IL-1R or CXCR2 signaling in vivo enhanced the efficacy of MAPK inhibitors. We conclude that melanoma inflammatory niches adapt to and confer drug tolerance toward BRAF and MEK inhibitors early during treatment." @default.
- W2606673077 created "2017-04-28" @default.
- W2606673077 creator A5005870582 @default.
- W2606673077 creator A5006833404 @default.
- W2606673077 creator A5007234389 @default.
- W2606673077 creator A5021099644 @default.
- W2606673077 creator A5023174631 @default.
- W2606673077 creator A5030079122 @default.
- W2606673077 creator A5035427219 @default.
- W2606673077 creator A5047185974 @default.
- W2606673077 creator A5047787126 @default.
- W2606673077 creator A5051175106 @default.
- W2606673077 creator A5053217678 @default.
- W2606673077 creator A5054179421 @default.
- W2606673077 creator A5071770314 @default.
- W2606673077 creator A5072096816 @default.
- W2606673077 creator A5082118845 @default.
- W2606673077 creator A5088889988 @default.
- W2606673077 creator A5089883984 @default.
- W2606673077 creator A5091070429 @default.
- W2606673077 date "2017-04-27" @default.
- W2606673077 modified "2023-10-17" @default.
- W2606673077 title "An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition" @default.
- W2606673077 cites W1494491432 @default.
- W2606673077 cites W1971750711 @default.
- W2606673077 cites W1973767497 @default.
- W2606673077 cites W1975748449 @default.
- W2606673077 cites W1992347215 @default.
- W2606673077 cites W2003402062 @default.
- W2606673077 cites W2017140048 @default.
- W2606673077 cites W2019544036 @default.
- W2606673077 cites W2020228504 @default.
- W2606673077 cites W2029081926 @default.
- W2606673077 cites W2032211985 @default.
- W2606673077 cites W2037542404 @default.
- W2606673077 cites W2043058822 @default.
- W2606673077 cites W2044341880 @default.
- W2606673077 cites W2047013291 @default.
- W2606673077 cites W2050516456 @default.
- W2606673077 cites W2055624262 @default.
- W2606673077 cites W2062275568 @default.
- W2606673077 cites W2064034345 @default.
- W2606673077 cites W2064672822 @default.
- W2606673077 cites W2065874620 @default.
- W2606673077 cites W2092437923 @default.
- W2606673077 cites W2092816381 @default.
- W2606673077 cites W2100614336 @default.
- W2606673077 cites W2105660237 @default.
- W2606673077 cites W2106543129 @default.
- W2606673077 cites W2107914050 @default.
- W2606673077 cites W2108373994 @default.
- W2606673077 cites W2109663505 @default.
- W2606673077 cites W2115785123 @default.
- W2606673077 cites W2116677194 @default.
- W2606673077 cites W2118863192 @default.
- W2606673077 cites W2120817406 @default.
- W2606673077 cites W2121936638 @default.
- W2606673077 cites W2123642955 @default.
- W2606673077 cites W2128542677 @default.
- W2606673077 cites W2131040858 @default.
- W2606673077 cites W2133557129 @default.
- W2606673077 cites W2140930678 @default.
- W2606673077 cites W2141674733 @default.
- W2606673077 cites W2142019721 @default.
- W2606673077 cites W2142160537 @default.
- W2606673077 cites W2143172913 @default.
- W2606673077 cites W2143580209 @default.
- W2606673077 cites W2145429129 @default.
- W2606673077 cites W2145866317 @default.
- W2606673077 cites W2148157688 @default.
- W2606673077 cites W2150266966 @default.
- W2606673077 cites W2151136040 @default.
- W2606673077 cites W2151832198 @default.
- W2606673077 cites W2156462327 @default.
- W2606673077 cites W2162942873 @default.
- W2606673077 cites W2163188200 @default.
- W2606673077 cites W2164704361 @default.
- W2606673077 cites W2168143310 @default.
- W2606673077 cites W2169390530 @default.
- W2606673077 cites W2169934850 @default.
- W2606673077 cites W2171710012 @default.
- W2606673077 cites W2208937711 @default.
- W2606673077 cites W2254594392 @default.
- W2606673077 cites W2531971527 @default.
- W2606673077 doi "https://doi.org/10.1084/jem.20160855" @default.
- W2606673077 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5460994" @default.
- W2606673077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28450382" @default.
- W2606673077 hasPublicationYear "2017" @default.
- W2606673077 type Work @default.
- W2606673077 sameAs 2606673077 @default.
- W2606673077 citedByCount "68" @default.
- W2606673077 countsByYear W26066730772017 @default.
- W2606673077 countsByYear W26066730772018 @default.
- W2606673077 countsByYear W26066730772019 @default.
- W2606673077 countsByYear W26066730772020 @default.
- W2606673077 countsByYear W26066730772021 @default.
- W2606673077 countsByYear W26066730772022 @default.
- W2606673077 countsByYear W26066730772023 @default.